N. Josselin

420 total citations
14 papers, 224 citations indexed

About

N. Josselin is a scholar working on Oncology, Molecular Biology and Dermatology. According to data from OpenAlex, N. Josselin has authored 14 papers receiving a total of 224 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Dermatology. Recurrent topics in N. Josselin's work include Cutaneous lymphoproliferative disorders research (3 papers), Bone health and treatments (2 papers) and Drug-Induced Adverse Reactions (2 papers). N. Josselin is often cited by papers focused on Cutaneous lymphoproliferative disorders research (3 papers), Bone health and treatments (2 papers) and Drug-Induced Adverse Reactions (2 papers). N. Josselin collaborates with scholars based in France and United States. N. Josselin's co-authors include Daniel Chappard, Borhane H. Fellah, Pierre Layrolle, Pierre Weiss, Serge Guyétant, Jean‐Paul Saint‐André, M.F. Baslé, Maurice Audran, Érick Legrand and Clotilde Rougé‐Maillart and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of the American Academy of Dermatology and Osteoporosis International.

In The Last Decade

N. Josselin

12 papers receiving 219 citations

Peers

N. Josselin
Emi Ogata Japan
Stacyann Bailey United States
Ibrahim Zakhary United States
David Antonio Cantu United States
Jing Ge China
A.B. Tran United States
Emi Ogata Japan
N. Josselin
Citations per year, relative to N. Josselin N. Josselin (= 1×) peers Emi Ogata

Countries citing papers authored by N. Josselin

Since Specialization
Citations

This map shows the geographic impact of N. Josselin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Josselin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Josselin more than expected).

Fields of papers citing papers by N. Josselin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Josselin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Josselin. The network helps show where N. Josselin may publish in the future.

Co-authorship network of co-authors of N. Josselin

This figure shows the co-authorship network connecting the top 25 collaborators of N. Josselin. A scholar is included among the top collaborators of N. Josselin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Josselin. N. Josselin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Josselin, N., et al.. (2020). Mycosis fongoïde bulleux : une présentation clinique exceptionnelle. Annales de Dermatologie et de Vénéréologie. 147(11). 760–763. 2 indexed citations
2.
Lassalle, Sandra, Sacha Nahon‐Estève, É. Frouin, et al.. (2020). PD-L1 Expression in 65 Conjunctival Melanomas and Its Association with Clinical Outcome. International Journal of Molecular Sciences. 21(23). 9147–9147. 12 indexed citations
3.
Bernier, C., et al.. (2018). Drug reaction with eosinophilia and systemic symptoms syndrome induced by combination of vemurafenib and cobimetinib in melanoma: A series of 11 cases. Journal of the American Academy of Dermatology. 80(2). 558–562. 9 indexed citations
4.
Perret, Raul, N. Josselin, Anne‐Chantal Knol, et al.. (2017). Histopathological aspects of cutaneous erythematous‐papular eruptions induced by immune checkpoint inhibitors for the treatment of metastatic melanoma. International Journal of Dermatology. 56(5). 527–533. 27 indexed citations
5.
Bernier, C., N. Josselin, L. Peuvrel, et al.. (2016). DRESS sous thérapie ciblée pour un mélanome : une série de 5 cas. Annales de Dermatologie et de Vénéréologie. 143(12). S216–S216.
6.
Quéreux, G., N. Josselin, M. Saint‐Jean, et al.. (2015). Exceptional Association of Syringotropic Mycosis Fungoides with Chronic Lymphocytic Leukaemia. Acta Dermato Venereologica. 96(2). 263–264.
7.
Josselin, N., Hélène Libouban, Mamoun Dib, et al.. (2008). Quantification of Dendritic Cells and Osteoclasts in the Bone Marrow of Patients with Monoclonal Gammopathy. Pathology & Oncology Research. 15(1). 65–72. 11 indexed citations
8.
Lavigne, Christian, et al.. (2007). Hypercalcémie et lymphome. À propos d'un cas. La Revue de Médecine Interne. 28(10). 714–715. 1 indexed citations
9.
Fellah, Borhane H., N. Josselin, Daniel Chappard, Pierre Weiss, & Pierre Layrolle. (2007). Inflammatory reaction in rats muscle after implantation of biphasic calcium phosphate micro particles. Journal of Materials Science Materials in Medicine. 18(2). 287–294. 58 indexed citations
10.
Chappard, Daniel, N. Josselin, Clotilde Rougé‐Maillart, et al.. (2006). Bone microarchitecture in males with corticosteroid-induced osteoporosis. Osteoporosis International. 18(4). 487–494. 32 indexed citations
12.
Letournel, Franck, et al.. (2004). Syndrome de Garcin révélant un lymphome malin non hodgkinien. Revue Neurologique. 160(10). 952–955. 6 indexed citations
13.
Guyétant, Serge, et al.. (2003). C-Cell Hyperplasia and Medullary Thyroid Carcinoma: Clinicopathological and Genetic Correlations in 66 Consecutive Patients. Modern Pathology. 16(8). 756–763. 28 indexed citations
14.
Josselin, N., et al.. (2002). Incidental Langerhans Cell Histiocytosis of Thyroid: Case Report and Review of the Literature. Endocrine Pathology. 13(3). 227–233. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026